TABLE 1.

Demographics of PSP participants

PSP demographics (n = 17)	Mean (range)
Age at symptom onset (y)	63 (51–73)
Gender, male/female	9:8
Time since onset of symptoms (y)	1.6 (0–6)
On antiparkinsonian medication	9/17
Phenotype (PSP‐RS:PSP‐P)	11:6
PSPRS—visit 1	37.1 (19–58)
MDS‐UPDRS, Part III—visit 1	43.9 (21–72)
MMSE—visit 1	26.2 (20–30)

Demographics, clinical characteristics, and cognitive scores of PSP participants.

Abbreviations: PSP, progressive supranuclear palsy; PSPRS, Progressive Supranuclear Palsy Rating Scale; MDS‐UPDRS, Movement Disorders Society‐Unified Parkinson's Disease Rating Scale; MMSE, Mini‐Mental State Examination.